Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Wearable Injectors Market

4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Wearable Injectors Market Analysis and Forecast, 2017–2031

5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry

6. Global Wearable Injectors Market Analysis and Forecast, by Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Type, 2017–2031
        6.3.1. On-body Wearable Injectors
        6.3.2. Off-body Wearable Injectors
    6.4. Market Attractiveness Analysis, by Type

7. Global Wearable Injectors Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Oncology
        7.3.2. Diabetes
        7.3.3. Autoimmune Disorders
        7.3.4. Cardiovascular Diseases
        7.3.5. Infectious Diseases
        7.3.6. Others
    7.4. Market Attractiveness Analysis, by Application

8. Global Wearable Injectors Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Clinics
        8.3.3. Home Care Settings
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by Application

9. Global Wearable Injectors Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region

10. North America Wearable Injectors Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Type, 2017–2031
        10.3.1. On-body Wearable Injectors
        10.3.2. Off-body Wearable Injectors
    10.4. Market Value Forecast, by Application, 2017–2031
        10.4.1. Oncology
        10.4.2. Diabetes
        10.4.3. Autoimmune Disorders
        10.4.4. Cardiovascular Diseases
        10.4.5. Infectious Diseases
        10.4.6. Others
    10.5. Market Value Forecast, by End-user, 2017–2031
        10.5.1. Hospitals
        10.5.2. Clinics
        10.5.3. Home Care Settings
        10.5.4. Others
    10.6. Market Value Forecast, by Country, 2017–2031
        10.6.1. U.S.
        10.6.2. Canada
    10.7. Market Attractiveness Analysis
        10.7.1. By Type
        10.7.2. By Application
        10.7.3. By End-user
        10.7.4. By Country

11. Europe Wearable Injectors Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Type, 2017–2031
        11.3.1. On-body Wearable Injectors
        11.3.2. Off-body Wearable Injectors
    11.4. Market Value Forecast, by Application, 2017–2031
        11.4.1. Oncology
        11.4.2. Diabetes
        11.4.3. Autoimmune Disorders
        11.4.4. Cardiovascular Diseases
        11.4.5. Infectious Diseases
        11.4.6. Others
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Hospitals
        11.5.2. Clinics
        11.5.3. Home Care Settings
        11.5.4. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Italy
        11.6.5. Spain
        11.6.6. Rest of Europe
    11.7. Market Attractiveness Analysis
        11.7.1. By Type
        11.7.2. By Application
        11.7.3. By End-user
        11.7.4. By Country/Sub-region

12. Asia Pacific Wearable Injectors Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Type, 2017–2031
        12.3.1. On-body Wearable Injectors
        12.3.2. Off-body Wearable Injectors
    12.4. Market Value Forecast, by Application, 2017–2031
        12.4.1. Oncology
        12.4.2. Diabetes
        12.4.3. Autoimmune Disorders
        12.4.4. Cardiovascular Diseases
        12.4.5. Infectious Diseases
        12.4.6. Others
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Hospitals
        12.5.2. Clinics
        12.5.3. Home Care Settings
        12.5.4. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
        12.7.1. By Type
        12.7.2. By Application
        12.7.3. By End-user
        12.7.4. By Country/Sub-region
13. Latin America Wearable Injectors Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Type, 2017–2031
        13.3.1. On-body Wearable Injectors
        13.3.2. Off-body Wearable Injectors
    13.4. Market Value Forecast, by Application, 2017–2031
        13.4.1. Oncology
        13.4.2. Diabetes
        13.4.3. Autoimmune Disorders
        13.4.4. Cardiovascular Diseases
        13.4.5. Infectious Diseases
        13.4.6. Others
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Hospitals
        13.5.2. Clinics
        13.5.3. Home Care Settings
        13.5.4. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
        13.7.1. By Type
        13.7.2. By Application
        13.7.3. By End-user
        13.7.4. By Country/Sub-region
14. Middle East & Africa Wearable Injectors Market Analysis and Forecast
    14.1. Introduction
    14.2. Key Findings
    14.3. Market Value Forecast, by Type, 2017–2031
        14.3.1. On-body Wearable Injectors
        14.3.2. Off-body Wearable Injectors
    14.4. Market Value Forecast, by Application, 2017–2031
        14.4.1. Oncology
        14.4.2. Diabetes
        14.4.3. Autoimmune Disorders
        14.4.4. Cardiovascular Diseases
        14.4.5. Infectious Diseases
        14.4.6. Others
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Hospitals
        14.5.2. Clinics
        14.5.3. Home Care Settings
        14.5.4. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. GCC Countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
        14.7.1. By Type
        14.7.2. By Application
        14.7.3. By End-user
        14.7.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. BD
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. F. Hoffmann-La Roche Ltd.
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Tandem Diabetes Care, Inc.
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Insulet Corporation
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Ypsomed AG
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. West Pharmaceutical Services, Inc.
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. CeQur Corporation
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. Debiotech S.A.
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Sensile Medical AG (Gerresheimer AG)
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview
        15.3.10. United Therapeutics Corporation
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Financial Overview
            15.3.10.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Wearable Injectors Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Wearable Injectors Market Revenue (US$ Mn), by Type, 2022

Figure 03: Global Wearable Injectors Market Value Share, by Type, 2022

Figure 04: Global Wearable Injectors Market Revenue (US$ Mn), by Application, 2022

Figure 05: Global Wearable Injectors Market Value Share, by Application, 2022

Figure 06: Global Wearable Injectors Market Revenue (US$ Mn), by End-user, 2022

Figure 07: Global Wearable Injectors Market Value Share, by End-user, 2022

Figure 08: Global Wearable Injectors Market Value Share, by Region, 2022

Figure 09: Global Wearable Injectors Market Value (US$ Mn) Forecast, 2023–2031

Figure 10: Global Wearable Injectors Market Value Share Analysis, by Type, 2022–2031

Figure 11: Global Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 12: Global Wearable Injectors Market Value Share Analysis, by Application, 2022–2031

Figure 13: Global Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031

Figure 14: Global Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031

Figure 15: Global Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 16: Global Wearable Injectors Market Value Share Analysis, by Region, 2022–2031

Figure 17: Global Wearable Injectors Market Attractiveness Analysis, by Region, 2023-2031

Figure 18: North America Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 19: North America Wearable Injectors Market Attractiveness Analysis, by Country, 2023–2031

Figure 20: North America Wearable Injectors Market Value Share Analysis, by Country, 2022–2031

Figure 21: North America Wearable Injectors Market Value Share Analysis, by Type, 2022–2031

Figure 22: North America Wearable Injectors Market Value Share Analysis, by Application, 2022–2031

Figure 23: North America Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031

Figure 24: North America Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031

Figure 25: North America Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031

Figure 26: North America Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031

Figure 27: Europe Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 29: Europe Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 30: Europe Wearable Injectors Market Value Share Analysis, by Type, 2022–2031

Figure 31: Europe Wearable Injectors Market Value Share Analysis, by Application, 2022–2031

Figure 32: Europe Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031

Figure 33: Europe Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031

Figure 34: Europe Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031

Figure 35: Europe Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031

Figure 36: Asia Pacific Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 37: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 38: Asia Pacific Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 39: Asia Pacific Wearable Injectors Market Value Share Analysis, by Type, 2022–2031

Figure 40: Asia Pacific Wearable Injectors Market Value Share Analysis, by Application, 2022–2031

Figure 41: Asia Pacific Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031

Figure 42: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031

Figure 43: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031

Figure 44: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031

Figure 45: Latin America Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 46: Latin America Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 47: Latin America Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 48: Latin America Wearable Injectors Market Value Share Analysis, by Type, 2022–2031

Figure 49: Latin America Wearable Injectors Market Value Share Analysis, by Application, 2022–2031

Figure 50: Latin America Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031

Figure 51: Latin America Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031

Figure 52: Latin America Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031

Figure 53: Latin America Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031

Figure 54: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 55: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 57: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Type, 2022–2031

Figure 58: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Application, 2022–2031

Figure 59: Middle East & Africa Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031

Figure 60: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031

Figure 61: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031

Figure 62: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031

List of Tables

List of Tables

Table 01: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 07: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 15: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 19: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031